Vitali Grozman

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Thoraxradiolog och forskare i gruppen Diagnostisk Radiologi, Institutionen
för Molekylär Medicin och Kirurgi (MMK), Karolinska Institutet.
Forskningsprojekt som rör lungcancerscreening, stereotaktisk radioterapi
(SBRT), interventionell thoraxradiologi, precision cancer medicine (PCM) och
artificiell intelligens (AI).

Artiklar

Article: ACTA ONCOLOGICA. 2023;62(12):1921-1930
Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and Tolerability
Backlund E; Grozman V; Brage SE; Lewensohn R; Lindberg K; Helgadottir H
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2023;117(5):1222-1231
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
Lindberg S; Grozman V; Karlsson K; Onjukka E; Lindback E; Al Jirf K; Lax I; Wersall P; Persson GF; Josipovic M; Khalil AA; Moller DS; Hoffmann L; Knap MM; Nyman J; Drugge N; Bergstrom P; Olofsson J; Rogg LV; Hagen RK; Froland A-S; Ramberg C; Kristiansen C; Jeppesen SS; Nielsen TB; Loden B; Rosenbrand H-O; Engelholm S; Haraldsson A; Billiet C; Lewensohn R; Lindberg K
Article: EMERGENCY RADIOLOGY. 2022;29(2):339-352
Deep learning versus iterative image reconstruction algorithm for head CT in trauma
Alagic Z; Cardenas JD; Halldorsson K; Grozman V; Wallgren S; Suzuki C; Helmenkamp J; Koskinen SK
Article: CANCERS. 2022;14(3):702
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
Costa Svedman F; Jalsenius M; Hoeiom V; Grozman V; Bergqvist M; Soederdahl F; Eriksson H; Rotstein S; Ny L; Ascierto PA; Brage SE; Helgadottir H
Article: MOLECULAR ONCOLOGY. 2021;15(11):2941-2957
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage
Franzen B; Viktorsson K; Kamali C; Darai-Ramqvist E; Grozman V; Arapi V; Haag P; Kaminskyy VO; Hydbring P; Kanter L; Nyren S; Ekman S; De Petris L; Lewensohn R
Article: PHYSICA MEDICA. 2021;88:53-64
Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy
Karlsson K; Lax I; Lindback E; Grozman V; Lindberg K; Wersall P; Poludniowski G
Article: JOURNAL OF THORACIC ONCOLOGY. 2021;16(7):1200-1210
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
Lindberg K; Grozman V; Karlsson K; Lindberg S; Lax I; Wersall P; Persson GF; Josipovic M; Khalil AA; Moeller DS; Nyman J; Drugge N; Bergstrom P; Olofsson J; Rogg LV; Ramberg C; Kristiansen C; Jeppesen SS; Nielsen TB; Loden B; Rosenbrand H-O; Engelholm S; Haraldsson A; Billiet C; Lewensohn R
Article: ACTA ONCOLOGICA. 2021;60(3):305-311
Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc-effects and side effects
Grozman V; Onjukka E; Wersall P; Lax I; Tsakonas G; Nyren S; Lewensohn R; Lindberg K
Article: CLINICAL LUNG CANCER. 2020;21(6):e544-e546
Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition
Tsakonas G; Grozman V; Ekman S
Article: ACTA ONCOLOGICA. 2019;58(8):1178-1186
Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersall P
Article: LUNG CANCER. 2018;120:75-81
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden
Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L
Article: LAKARTIDNINGEN. 2010;107(7):440-443
[Spinal dural arteriovenous fistula--uncommon, curable cause of paraplegia. Early diagnosis and treatment can result in total symptom regression].
Grozman V; Svensson M; Holmin S; Andersson T; Söderman M

Alla övriga publikationer

Letter: ACTA ONCOLOGICA. 2022;61(9):1116-1120
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy
Costa Svedman F; Jalsenius M; Grozman V; Bergqvist M; Soderdahl F; Rotstein S; Ny L; Egyhazi Brage S; Helgadottir H
Letter: ACTA ONCOLOGICA. 2022;61(7):869-873
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial
Backlund E; Yang M; Grozman V; Masucci G; Falkenius J; Eriksson H; Jovanovic B; Hammarlund K; Isacsson U; Radu C; Abel E; Karlsson K; Palanco Zamora R; Wersall P; Edback U; Wickstrom S; Darai Ramqvist E; Egyhazi Brage S; Kiessling R; Viktorsson K; Franzen B; Lewensohn R; Olofsson Bagge R; Ullenhag GJ; Ny L; Lindberg K; Helgadottir H
Thesis / dissertation: 2022
SBRT of large tumors and tumors located near organs at risk in the thoracic cavity
Grozman, Vitali
Corrigendum: LUNG CANCER. 2018;123:178-179
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden (vol 120, pg 75, 2018)
Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2022
Läkarexamen, Karolinska Institutet, 2008

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI